496 related articles for article (PubMed ID: 25962088)
1. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
Bokharaei-Salim F; Esghaei M; Khanaliha K; Kalantari S; Marjani A; Fakhim A; Keyvani H
PLoS One; 2020; 15(3):e0229275. PubMed ID: 32119691
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HIV-1 pre-treatment drug resistance in a southern province of Iran, 2016-2017.
Memarnejadian A; Gouklani H; Mohammadi S; Moosazadeh M; Choi J
Arch Virol; 2018 Jan; 163(1):57-63. PubMed ID: 28983848
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
[TBL] [Abstract][Full Text] [Related]
6. The Frequency of HIV-1 Infection in Iranian Children and Determination of the Transmitted Drug Resistance in Treatment-Naïve Children.
Jarchi M; Bokharaei-Salim F; Esghaei M; Kiani SJ; Jahanbakhsh F; Monavari SH; Ataei-Pirkooh A; Marjani A; Keyvani H
Curr HIV Res; 2019; 17(6):397-407. PubMed ID: 31702525
[TBL] [Abstract][Full Text] [Related]
7. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
Jahanbakhsh F; Hattori J; Matsuda M; Ibe S; Monavari SH; Memarnejadian A; Aghasadeghi MR; Mostafavi E; Mohraz M; Jabbari H; Kamali K; Keyvani H; Azadmanesh K; Sugiura W
PLoS One; 2013; 8(4):e61864. PubMed ID: 23626742
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
11. Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.
Lan Y; Li L; He X; Hu F; Deng X; Cai W; Li J; Ling X; Fan Q; Cai X; Li L; Li F; Tang X
Virol J; 2021 Sep; 18(1):181. PubMed ID: 34488793
[TBL] [Abstract][Full Text] [Related]
12. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
Ross LL; Shortino D; Shaefer MS
AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
[TBL] [Abstract][Full Text] [Related]
13. HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.
Farrokhi M; Moallemi S; Baesi K; Ahsani-Nasab S; Gholami M; Sadeghi L; Mohraz M
Intervirology; 2016; 59(3):131-136. PubMed ID: 27974715
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam.
Thao VP; Le T; Török EM; Yen NT; Chau TT; Jurriaans S; van Doorn HR; de Jong MD; Farrar JJ; Dunstan SJ
Antivir Ther; 2012; 17(5):905-13. PubMed ID: 22473024
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection.
Manosuthi W; Thongyen S; Nilkamhang S; Manosuthi S; Sungkanuparph S
J Med Virol; 2013 Feb; 85(2):194-9. PubMed ID: 23161095
[TBL] [Abstract][Full Text] [Related]
16. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
[TBL] [Abstract][Full Text] [Related]
17. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
Mulu A; Maier M; Liebert UG
PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
[TBL] [Abstract][Full Text] [Related]
18. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
[TBL] [Abstract][Full Text] [Related]
19. Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals.
Winand R; Theys K; Eusébio M; Aerts J; Camacho RJ; Gomes P; Suchard MA; Vandamme AM; Abecasis AB;
AIDS; 2015 Sep; 29(15):2045-52. PubMed ID: 26355575
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of drug-resistant HIV type 1 at the time of initiation of antiretroviral therapy in Portland, Oregon.
MacVeigh MS; Kosmetatos MK; McDonald JE; Reeder JL; Parrish DA; Young TP
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):337-42. PubMed ID: 22697610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
